Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results
Darell D. Bigner, Mark T. Brown, Allan H. Friedman, R. Edward Coleman, Gamal Akabani, Henry S. Friedman, Wade L. Thorstad, Roger E. McLendon, Sandra H. Bigner, Xiao Guang Zhao, Charles N. Pegram, Carol J. Wikstrand, James E. Herndon, Nicholas A. Vick, Nina Paleologos, Ilkcan Cokgor, James M. Provenzale, Michael R. Zalutsky
Dive into the research topics of 'Iodine-131-labeled antitenascin monoclonal antibody 81C6 treatment of patients with recurrent malignant gliomas: Phase I trial results'. Together they form a unique fingerprint.